I want to help prevent and alleviate suffering in the poorest, sickest, most vulnerable and discriminated people.
I have over 7 years' experience in statistics applied to public health / medical research and 4 years in clinical psychiatry.
I have researched areas of poverty, Aboriginal health, communicable diseases (influenza-oseltamivir prophylaxis, Tuberculosis, syphilis, HIV, sexually transmitted infections), mental health, addictions, crime, cancer, heart disease, smoking cessation, breastfeeding, health and well-being, health education, aged care and for children with disabilities.
Biostatistics: Generalised Linear Models, Survival Analysis, Longitudinal and Correlated Data (including multi-level modelling), Advanced R, Stata, Meta-regression, Study Design, Sample Size Calculation, Logic, Variable Selection, Data Linkage, Clinical Trial Design, Probability & Statistical Inference, Pharmacoepidemiology, generating and simulating data, multiple imputation for analysis with missing data and an overview of Machine Learning
Causal Inference: Directed Acyclic Graphs, Propensity Scores, Inverse Probability Treatment Weights, Regression Discontinuity, Differences in Differences, Instrumental Variables, Mendelian Randomisation
Rotations: Rural and Indigenous Health, HIV, Public Health Unit (Communicable Disease and Environmental Health), Childhood Disability, Addiction and Pharmacoepi (TGA)
Coursework: Environmental Health Risk Assessments | Framing Indigenous Health| Health Promotion| Health Policy| Epidemiology and Control of Communicable Disease| Qualitative Research Methods| Environmental Health Risk Assessments | Introduction to teaching and supervision | Grant Writing | PRINCE 2 : Foundations and Practitioners | Good Clinical Practice (GCP) Certified as of 2022 Oct
Conference Presentations: National Rural Health (Oral) | Asia Pacific Heart Failure (2 Posters) 2008 | RACP 2016 (Oral: Gerry Murphy Prize) |Australian Public Health 2019 (Oral)
University of Sydney, NHMRC Clinical Trial Centre
Risk and Treatment Factors of Squamous Cell Carcinoma of the Lip
MBBS BMedSc First Class Honours in Biostatistics
University of Melbourne
to December 2010
A Pharmacological mechanism for the Clinical Benefits of Angiotensin Converting Enzyme Inhibitors: Analyses of randomised controlled trials